Compass Therapeutics, Inc.
CMPX
$1.97
$0.105.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.55% | -10.22% | 28.28% | -19.53% | -10.64% |
| Total Depreciation and Amortization | -0.54% | -0.27% | 1.09% | 0.82% | 1.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 673.77% | -27.11% | -67.59% | 4.84% | 29.07% |
| Change in Net Operating Assets | -386.19% | -32.77% | -56.64% | 863.34% | -85.30% |
| Cash from Operations | -30.29% | -22.17% | 8.31% | 10.42% | -44.16% |
| Capital Expenditure | -- | 100.00% | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,240.05% | 96.45% | -1,396.05% | -154.80% | -24.49% |
| Cash from Investing | 1,237.63% | 96.45% | -1,396.16% | -154.88% | -24.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 202.27% | -99.08% | -- | -- | -- |
| Repurchase of Common Stock | -130.66% | -- | -- | 100.00% | -748.96% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | 216.56% | -99.18% | -- | 100.00% | -767.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 257.52% | -166.66% | 228.39% | -647.10% | -136.44% |